Acta Scientific Ophthalmology (ISSN: 2582-3191)

Review Article Volume 4 Issue 11

The Value of OCT GCIPL Parameters in Neuro-Ophthalmology- A Review Article

Ahmed Darwish*

Professor of Ophthalmology, Ain Shams University, Egypt and Vitreoretinal Surgery Consultant at Dhahran Eye Specialist Hospital, KSA

*Corresponding Author: Ahmed Darwish, Professor of Ophthalmology, Ain Shams University, Egypt and Vitreoretinal Surgery Consultant at Dhahran Eye Specialist Hospital, KSA.

Received: August 27, 2021; Published: October 04, 2021

×

Abstract

Purpose: Currently, segmentation of individual retinal layer is possible using spectral-domain OCT (SD-OCT). The Ganglion Cell/Inner plexiform layer (GCIPL) investigation has become one of the most useful tools in neuro-ophthalmic practice. In this review we shall point out the value of this investigative tool in neuro-ophthalmology.

Methods: To evaluate the above-mentioned item based on recently published data.

Results: GCIPL analysis may provide earlier information about neuronal damage than retinal nerve fiber layer (RNFL) analysis in neuro-ophthalmic disorders.

Conclusion: Optical coherence tomography GCIPL testing has proved to be an important non invasive less time consuming test in the diagnosis, treatment, and follow-up of optic neuropathies.

Keywords: Neuro-Ophthalmology; SD OCT; Optical Coherence Tomography; Ganglion Cell Inner Plexiform Layer

×

References

  1. Costello F. “The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis”. ISRN Neurology (2013): 134858.
  2. Chen JJ and Kardon RH. “Avoiding Clinical Misinterpretation and Artifacts of Optical Coherence Tomography Analysis of the Optic Nerve, Retinal Nerve Fiber Layer, and Ganglion Cell Layer”. Journal of Neuro-Ophthalmology 36 (2016): 417-438.
  3. Chen JJ and Costello F. “The role of optical coherence tomography in neuro-ophthalmology (2018).
  4. Chen JJ., et al. “Causes and Prognosis of Visual Acuity Loss at the Time of Initial Presentation in Idiopathic Intracranial Hypertension”. Investigative Ophthalmology and Visual Science 56 (2015): 3850-3859.
  5. Brandt AU., et al. “Monitoring the Course of MS With Optical Coherence Tomography”. Current Treatment Options in Neurology 19 (2017): 15.
  6. Bennett JL., et al. “Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography”. Multiple Sclerosis Journal 21 (2015): 678-688.
  7. Petzold A., et al. “Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis”. The Lancet Neurology 16 (2017): 797-812.
  8. Thompson AJ., et al. “Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria”. The Lancet Neurology 17 (2018): 162-173.
  9. Rebolleda G., et al. “Ganglion cell layer analysis unmasks axonal loss in anterior optic neuritis”. Journal of Neuro-Ophthalmology 2 (2014): 165-167.
  10. Rebolleda G., et al. “Neuro-ophthalmology Update OCT: New perspectives in neuro-ophthalmology”. Saudi Journal of Ophthalmology 29 (2015): 9-25.
  11. Eugenia IR. “The role of Optical Coherence Tomography in optic neuropathies”. Romanian Journal of Ophthalmology1 (2018): 3-14.
  12. Barboni P., et al. “Retinal nerve fiber layer evaluation by optical coherence tomography in Leber’s hereditary optic neuropathy”. Ophthalmology 112 (2005): 120-126.
  13. Loo JL., et al. “Use of optical coherence tomography in predicting post-treatment visual outcome in anterior visual pathway meningiomas”. British Journal of Ophthalmology11 (2013): 1455-1458.
  14. Grzybowski A and Barboni P. “OCT in central nervous system disease. The eye as a window to the brain, 2016, Switzerland, Springer International Publishing (2016): 73.
  15. Forte R., et al. “Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in tyroid-associated orbitopathy”. Ophtalmologica2 (2010): 116-121.
  16. Tieger MG., et al. “Ganglion Cell Complex Loss in Chiasmal Compression by Brain Tumors”. Journal of Neuro-Ophthalmology 37 (2017): 7-12.
  17. Yum HR., et al. “Macular Ganglion Cell Analysis Determined by Cirrus HD Optical Coherence Tomography for Early Detecting Chiasmal Compression”. PLoS One 11 (2016): e0153064.
  18. Wang MY and Sadun AA. “Drug-related mitochondrial optic neuropathies”. Journal of Neuro-Ophthalmology 33 (2013): 172-178.
  19. Kinoshita J., et al. “Retinal function and morphology in monkeys with ethambutol-induced optic neuropathy”. Investigative Ophthalmology and Visual Science 53 (2012): 7052-7062.
  20. , et al. “BMC Ophthalmology. Analysis of structural injury patterns in peripapillary retinal nerve fibre layer and retinal ganglion cell layer in ethambutol induced optic neuropathy 21 (2021): 132.
×

Citation

Citation: Ahmed Darwish. “The Value of OCT GCIPL Parameters in Neuro-Ophthalmology- A Review Article".Acta Scientific Ophthalmology 4.11 (2021): 07-13.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 25, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US